Metropolis Healthcare shareholding pattern

METROPOLIS

1860.1

39.30 (-2.07%)
Last updated on 20 Feb, 2026 | 15:47 IST
alert_iconwatchlist_icon
BUYSELL
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Metropolis Healthcare Shareholding Pattern

  • 2018-19
  • 2019-20
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2020-21
Total Promoters
Segment
Percent

Total Promoters

49.4%

Mutual Fund

26.37%

Insurance

3.5%

Foreign Institutional Investors

16.73%

Domestic Institutional Investors

0.13%

Retail

3.87%

Others

0%

Total Promoters
MAR '24
49.67%
JUN '24
49.62%
SEP '24
49.43%
DEC '24
49.4%

Summary

For Year 2025-26, Metropolis Healthcare reports the following shareholding: Total Promoters at 48.88%, Mutual Fund at 32.22%, Insurance at 2.16%, Foreign Institutional Investors at 11.68%, Domestic Institutional Investors at 0.36%, and Retail at 4.71%. This breakdown provides a quick snapshot of ownership distribution for Metropolis Healthcare in 2025-26.

Metropolis Healthcare FAQs

As of 02-2026, the promoter shareholding in Metropolis Healthcare stands at 48.88% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Metropolis Healthcare is 11.68% and 0.36% respectively.

The retail shareholding of the Metropolis Healthcare is 4.71%.

Changes in shareholding patterns of Metropolis Healthcare can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Metropolis Healthcare are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost